Global Favipiravir Market Growth 2020-2025
According to this study, over the next five years the Favipiravir market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Favipiravir business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Favipiravir market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Favipiravir, covering the supply chain analysis, impact assessment to the Favipiravir market size growth rate in several scenarios, and the measures to be undertaken by Favipiravir companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Original Drug
Generic Drug
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Influenza Viruses
HIV
SARS
Ebola
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Fujifilm Toyama Chemical
CSPC Pharmaceutical Group
Sihuan Pharmaceutical
Hisun Pharm
Reyoung Pharmaceutical
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Favipiravir consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Favipiravir market by identifying its various subsegments.
Focuses on the key global Favipiravir manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Favipiravir with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Favipiravir submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Favipiravir Consumption 2015-2025
2.1.2 Favipiravir Consumption CAGR by Region
2.2 Favipiravir Segment by Type
2.2.1 Original Drug
2.2.2 Generic Drug
2.3 Favipiravir Consumption by Type
2.3.1 Global Favipiravir Consumption Market Share by Type (2015-2020)
2.3.2 Global Favipiravir Revenue and Market Share by Type (2015-2020)
2.3.3 Global Favipiravir Sale Price by Type (2015-2020)
2.4 Favipiravir Segment by Application
2.4.1 Influenza Viruses
2.4.2 HIV
2.4.3 SARS
2.4.4 Ebola
2.4.5 Other
2.5 Favipiravir Consumption by Application
2.5.1 Global Favipiravir Consumption Market Share by Type (2015-2020)
2.5.2 Global Favipiravir Value and Market Share by Type (2015-2020)
2.5.3 Global Favipiravir Sale Price by Type (2015-2020)
3 Global Favipiravir by Company
3.1 Global Favipiravir Sales Market Share by Company
3.1.1 Global Favipiravir Sales by Company (2018-2020)
3.1.2 Global Favipiravir Sales Market Share by Company (2018-2020)
3.2 Global Favipiravir Revenue Market Share by Company
3.2.1 Global Favipiravir Revenue by Company (2018-2020)
3.2.2 Global Favipiravir Revenue Market Share by Company (2018-2020)
3.3 Global Favipiravir Sale Price by Company
3.4 Global Favipiravir Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Favipiravir Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Favipiravir Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Favipiravir by Regions
4.1 Favipiravir by Regions
4.2 Americas Favipiravir Consumption Growth
4.3 APAC Favipiravir Consumption Growth
4.4 Europe Favipiravir Consumption Growth
4.5 Middle East & Africa Favipiravir Consumption Growth
5 Americas
5.1 Americas Favipiravir Consumption by Countries
5.1.1 Americas Favipiravir Consumption by Countries (2015-2020)
5.1.2 Americas Favipiravir Value by Countries (2015-2020)
5.2 Americas Favipiravir Consumption by Type
5.3 Americas Favipiravir Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Favipiravir Consumption by Regions
6.1.1 APAC Favipiravir Consumption by Regions (2015-2020)
6.1.2 APAC Favipiravir Value by Regions (2015-2020)
6.2 APAC Favipiravir Consumption by Type
6.3 APAC Favipiravir Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Favipiravir by Countries
7.1.1 Europe Favipiravir Consumption by Countries (2015-2020)
7.1.2 Europe Favipiravir Value by Countries (2015-2020)
7.2 Europe Favipiravir Consumption by Type
7.3 Europe Favipiravir Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Favipiravir by Countries
8.1.1 Middle East & Africa Favipiravir Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Favipiravir Value by Countries (2015-2020)
8.2 Middle East & Africa Favipiravir Consumption by Type
8.3 Middle East & Africa Favipiravir Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Favipiravir Distributors
10.3 Favipiravir Customer
11 Global Favipiravir Market Forecast
11.1 Global Favipiravir Consumption Forecast (2021-2025)
11.2 Global Favipiravir Forecast by Regions
11.2.1 Global Favipiravir Forecast by Regions (2021-2025)
11.2.2 Global Favipiravir Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast byRegions
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Favipiravir Forecast by Type
11.8 Global Favipiravir Forecast by Application
12 Key Players Analysis
12.1 Fujifilm Toyama Chemical
12.1.1 Company Information
12.1.2 Favipiravir Product Offered
12.1.3 Fujifilm Toyama Chemical Favipiravir Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Fujifilm Toyama Chemical Latest Developments
12.2 CSPC Pharmaceutical Group
12.2.1 Company Information
12.2.2 Favipiravir Product Offered
12.2.3 CSPC Pharmaceutical Group Favipiravir Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 CSPC Pharmaceutical Group Latest Developments
12.3 Sihuan Pharmaceutical
12.3.1 Company Information
12.3.2 Favipiravir Product Offered
12.3.3 Sihuan Pharmaceutical Favipiravir Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Sihuan Pharmaceutical Latest Developments
12.4 Hisun Pharm
12.4.1 Company Information
12.4.2 Favipiravir Product Offered
12.4.3 Hisun Pharm Favipiravir Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Hisun Pharm Latest Developments
12.5 Reyoung Pharmaceutical
12.5.1 Company Information
12.5.2 Favipiravir Product Offered
12.5.3 Reyoung Pharmaceutical Favipiravir Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Reyoung Pharmaceutical Latest Developments
...
13 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Favipiravir Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Original Drug
Table 5. Major Players of Generic Drug
Table 6. Global Consumption Sales by Type (2015-2020)
Table 7. Global Favipiravir Consumption Market Share by Type (2015-2020)
Table 8. Global Favipiravir Revenue by Type (2015-2020) ($ million)
Table 9. Global Favipiravir Value Market Share by Type (2015-2020) ($ Millions)
Table 10. Global Favipiravir Sale Price by Type (2015-2020)
Table 11. Global Consumption Sales by Application (2015-2020)
Table 12. Global Favipiravir Consumption Market Share by Application (2015-2020)
Table 13. Global Favipiravir Value by Application (2015-2020)
Table 14. Global Favipiravir Value Market Share by Application (2015-2020)
Table 15. Global Favipiravir Sale Price by Application (2015-2020)
Table 16. Global Favipiravir Sales by Company (2017-2019) (K Units)
Table 17. Global Favipiravir Sales Market Share by Company (2017-2019)
Table 18. Global Favipiravir Revenue by Company (2017-2019) ($ Millions)
Table 19. Global Favipiravir Revenue Market Share by Company (2017-2019)
Table 20. Global Favipiravir Sale Price by Company (2017-2019)
Table 21. Global Favipiravir Manufacturing Base Distribution and Sales Area by Manufacturers
Table 22. Players Favipiravir Products Offered
Table 23. Favipiravir Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 24. Global Favipiravir Consumption by Regions 2015-2020 (K Units)
Table 25. Global Favipiravir Consumption Market Share by Regions 2015-2020
Table 26. Global Favipiravir Value by Regions 2015-2020 ($ Millions)
Table 27. Global Favipiravir Value Market Share by Regions 2015-2020
Table 28. Americas Favipiravir Consumption by Countries (2015-2020) (K Units)
Table 29. Americas Favipiravir Consumption Market Share by Countries (2015-2020)
Table 30. Americas Favipiravir Value by Countries (2015-2020) ($ Millions)
Table 31. Americas Favipiravir Value Market Share by Countries (2015-2020)
Table 32. Americas Favipiravir Consumption by Type (2015-2020) (K Units)
Table 33. Americas Favipiravir Consumption Market Share by Type (2015-2020)
Table 34. Americas Favipiravir Consumption by Application (2015-2020) (K Units)
Table 35. Americas Favipiravir Consumption Market Share by Application (2015-2020)
Table 36. APAC Favipiravir Consumption by Regions (2015-2020) (K Units)
Table 37. APAC Favipiravir Consumption Market Share by Regions (2015-2020)
Table 38. APAC Favipiravir Value by Regions (2015-2020) ($ Millions)
Table 39. APAC Favipiravir Value Market Share by Regions (2015-2020)
Table 40. APAC Favipiravir Consumption by Type (2015-2020) (K Units)
Table 41. APAC Favipiravir Consumption Market Share by Type (2015-2020)
Table 42. APAC Favipiravir Consumption by Application (2015-2020) (K Units)
Table 43. APAC Favipiravir Consumption Market Share by Application (2015-2020)
Table 44. Europe Favipiravir Consumption by Countries (2015-2020) (K Units)
Table 45. Europe Favipiravir Consumption Market Share by Countries (2015-2020)
Table 46. Europe Favipiravir Value by Countries (2015-2020) ($ Millions)
Table 47. Europe Favipiravir Value Market Share by Countries (2015-2020)
Table 48. Europe Favipiravir Consumption by Type (2015-2020) (K Units)
Table 49. Europe Favipiravir Consumption Market Share by Type (2015-2020)
Table 50. Europe Favipiravir Consumption by Application (2015-2020) (K Units)
Table 51. Europe Favipiravir Consumption Market Share by Application (2015-2020)
Table 52. Middle East & Africa Favipiravir Consumption by Countries (2015-2020) (K Units)
Table 53. Middle East & Africa Favipiravir Consumption Market Share by Countries (2015-2020)
Table 54. Middle East & Africa Favipiravir Value by Countries (2015-2020) ($ Millions)
Table 55. Middle East & Africa Favipiravir Value Market Share by Countries (2015-2020)
Table 56. Middle East & Africa Favipiravir Consumption by Type (2015-2020) (K Units)
Table 57. Middle East & Africa Favipiravir Consumption Market Share by Type (2015-2020)
Table 58. Middle East & Africa Favipiravir Consumption by Application (2015-2020) (K Units)
Table 59. Middle East & Africa Favipiravir Consumption Market Share by Application (2015-2020)
Table 60. Favipiravir Distributors List
Table 61. Favipiravir Customer List
Table 62. Global Favipiravir Consumption Forecast by Countries (2021-2025) (K Units)
Table 63. Global Favipiravir Consumption Market Forecast by Regions
Table 64. Global Favipiravir Value Forecast by Countries (2021-2025) ($ Millions)
Table 65. Global Favipiravir Value Market Share Forecast by Regions
Table 66. Global Favipiravir Consumption Forecast by Type (2021-2025) (K Units)
Table 67. Global Favipiravir Consumption Market Share Forecast by Type (2021-2025)
Table 68. Global Favipiravir Value Forecast by Type (2021-2025) ($ Millions)
Table 69. Global Favipiravir Value Market Share Forecast by Type (2021-2025)
Table 70. Global Favipiravir Consumption Forecast by Application (2021-2025) (K Units)
Table 71. Global Favipiravir Consumption Market Share Forecast by Application (2021-2025)
Table 72. Global Favipiravir Value Forecast by Application (2021-2025) ($ Millions)
Table 73. Global Favipiravir Value Market Share Forecast by Application (2021-2025)
Table 74. Fujifilm Toyama Chemical Product Offered
Table 75. Fujifilm Toyama Chemical Favipiravir Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 76. Fujifilm Toyama Chemical Main Business
Table 77. Fujifilm Toyama Chemical Latest Developments
Table 78. Fujifilm Toyama Chemical Basic Information, Company Total Revenue (in $ million), Favipiravir Manufacturing Base, Sales Area and Its Competitors
Table 79. CSPC Pharmaceutical Group Product Offered
Table 80. CSPC Pharmaceutical Group Favipiravir Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 81. CSPC Pharmaceutical Group Main Business
Table 82. CSPC Pharmaceutical Group Latest Developments
Table 83. CSPC Pharmaceutical Group Basic Information, Company Total Revenue (in $ million), Favipiravir Manufacturing Base, Sales Area and Its Competitors
Table 84. Sihuan Pharmaceutical Product Offered
Table 85. Sihuan Pharmaceutical Favipiravir Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 86. Sihuan Pharmaceutical Main Business
Table 87. Sihuan Pharmaceutical Latest Developments
Table 88. Sihuan Pharmaceutical Basic Information, Company Total Revenue (in $ million), Favipiravir Manufacturing Base, Sales Area and Its Competitors
Table 89. Hisun Pharm Product Offered
Table 90. Hisun Pharm Favipiravir Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 91. Hisun Pharm Main Business
Table 92. Hisun Pharm Latest Developments
Table 93. Hisun Pharm Basic Information, Company Total Revenue (in $ million), Favipiravir Manufacturing Base, Sales Area and Its Competitors
Table 94. Reyoung Pharmaceutical Product Offered
Table 95. Reyoung Pharmaceutical Favipiravir Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 96. Reyoung Pharmaceutical Main Business
Table 97. Reyoung Pharmaceutical Latest Developments
Table 98. Reyoung Pharmaceutical Basic Information, Company Total Revenue (in $ million), Favipiravir Manufacturing Base, Sales Area and Its Competitors
List of Figures
Figure 1. Picture of Favipiravir
Figure 2. Favipiravir Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Favipiravir Consumption Growth Rate 2015-2025 (K Units)
Figure 5. Global Favipiravir Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Original Drug
Figure 7. Product Picture of Generic Drug
Figure 8. Global Favipiravir Consumption Market Share by Type (2015-2020)
Figure 9. Global Favipiravir Value Market Share by Type (2015-2020)
Figure 10. Favipiravir Consumed in Influenza Viruses
Figure 11. Global Favipiravir Market: Influenza Viruses (2015-2020) (K Units)
Figure 12. Global Favipiravir Market: Influenza Viruses (2015-2020) ($ Millions)
Figure 13. Favipiravir Consumed in HIV
Figure 14. Global Favipiravir Market: HIV (2015-2020) (K Units)
Figure 15. Global Favipiravir Market: HIV (2015-2020) ($ Millions)
Figure 16. Favipiravir Consumed in SARS
Figure 17. Global Favipiravir Market: SARS (2015-2020) (K Units)
Figure 18. Global Favipiravir Market: SARS (2015-2020) ($ Millions)
Figure 19. Favipiravir Consumed in Ebola
Figure 20. Global Favipiravir Market: Ebola (2015-2020) (K Units)
Figure 21. Global Favipiravir Market: Ebola (2015-2020) ($ Millions)
Figure 22. Favipiravir Consumed in Other
Figure 23. Global Favipiravir Market: Other (2015-2020) (K Units)
Figure 24. Global Favipiravir Market: Other (2015-2020) ($ Millions)
Figure 25. Global Favipiravir Consumption Market Share by Application (2015-2020)
Figure 26. Global Favipiravir Value Market Share by Application (2015-2020)
Figure 27. Global Favipiravir Sales Market Share by Company in 2017
Figure 28. Global Favipiravir Sales Market Share by Company in 2019
Figure 29. Global Favipiravir Revenue Market Share by Company in 2017
Figure 30. Global Favipiravir Revenue Market Share by Company in 2019
Figure 31. Global Favipiravir Sale Price by Company in 2019
Figure 32. Global Favipiravir Consumption Market Share by Regions 2015-2020
Figure 33. Global Favipiravir Value Market Share by Regions 2015-2020
Figure 34. Americas Favipiravir Consumption 2015-2020 (K Units)
Figure 35. Americas Favipiravir Value 2015-2020 ($ Millions)
Figure 36. APAC Favipiravir Consumption 2015-2020 (K Units)
Figure 37. APAC Favipiravir Value 2015-2020 ($ Millions)
Figure 38. Europe Favipiravir Consumption 2015-2020 (K Units)
Figure 39. Europe Favipiravir Value 2015-2020 ($ Millions)
Figure 40. Middle East & Africa Favipiravir Consumption 2015-2020 (K Units)
Figure 41. Middle East & Africa Favipiravir Value 2015-2020 ($ Millions)
Figure 42. Americas Favipiravir Consumption Market Share by Countries in 2019
Figure 43. Americas Favipiravir Value Market Share by Countries in 2019
Figure 44. Americas Favipiravir Consumption Market Share by Type in 2019
Figure 45. Americas Favipiravir Consumption Market Share by Application in 2019
Figure 46. United States Favipiravir Consumption Growth 2015-2020 (K Units)
Figure 47. United States Favipiravir Value Growth 2015-2020 ($ Millions)
Figure 48. Canada Favipiravir Consumption Growth 2015-2020 (K Units)
Figure 49. Canada Favipiravir Value Growth 2015-2020 ($ Millions)
Figure 50. Mexico Favipiravir Consumption Growth 2015-2020 (K Units)
Figure 51. Mexico Favipiravir Value Growth 2015-2020 ($ Millions)
Figure 52. APAC Favipiravir Consumption Market Share by Countries in 2019
Figure 53. APAC Favipiravir Value Market Share by Regions in 2019
Figure 54. APAC Favipiravir Consumption Market Share by Type in 2019
Figure 55. APAC Favipiravir Consumption Market Share by Application in 2019
Figure 56. China Favipiravir Consumption Growth 2015-2020 (K Units)
Figure 57. China Favipiravir Value Growth 2015-2020 ($ Millions)
Figure 58. Japan Favipiravir Consumption Growth 2015-2020 (K Units)
Figure 59. Japan Favipiravir Value Growth 2015-2020 ($ Millions)
Figure 60. Korea Favipiravir Consumption Growth 2015-2020 (K Units)
Figure 61. Korea Favipiravir Value Growth 2015-2020 ($ Millions)
Figure 62. Southeast Asia Favipiravir Consumption Growth 2015-2020 (K Units)
Figure 63. Southeast Asia Favipiravir Value Growth 2015-2020 ($ Millions)
Figure 64. India Favipiravir Consumption Growth 2015-2020 (K Units)
Figure 65. India Favipiravir Value Growth 2015-2020 ($ Millions)
Figure 66. Australia Favipiravir Consumption Growth 2015-2020 (K Units)
Figure 67. Australia Favipiravir Value Growth 2015-2020 ($ Millions)
Figure 68. Europe Favipiravir Consumption Market Share by Countries in 2019
Figure 69. Europe Favipiravir Value Market Share by Countries in 2019
Figure 70. Europe Favipiravir Consumption Market Share by Type in 2019
Figure 71. Europe Favipiravir Consumption Market Share by Application in 2019
Figure 72. Germany Favipiravir Consumption Growth 2015-2020 (K Units)
Figure 73. Germany Favipiravir Value Growth 2015-2020 ($ Millions)
Figure 74. France Favipiravir Consumption Growth 2015-2020 (K Units)
Figure 75. France Favipiravir Value Growth 2015-2020 ($ Millions)
Figure 76. UK Favipiravir Consumption Growth 2015-2020 (K Units)
Figure 77. UK Favipiravir Value Growth 2015-2020 ($ Millions)
Figure 78. Italy Favipiravir Consumption Growth 2015-2020 (K Units)
Figure 79. Italy Favipiravir Value Growth 2015-2020 ($ Millions)
Figure 80. Russia Favipiravir Consumption Growth 2015-2020 (K Units)
Figure 81. Russia Favipiravir Value Growth 2015-2020 ($ Millions)
Figure 82. Middle East & Africa Favipiravir Consumption Market Share by Countries in 2019
Figure 83. Middle East & Africa Favipiravir Value Market Share by Countries in 2019
Figure 84. Middle East & Africa Favipiravir Consumption Market Share by Type in 2019
Figure 85. Middle East & Africa Favipiravir Consumption Market Share by Application in 2019
Figure 86. Egypt Favipiravir Consumption Growth 2015-2020 (K Units)
Figure 87. Egypt Favipiravir Value Growth 2015-2020 ($ Millions)
Figure 88. South Africa Favipiravir Consumption Growth 2015-2020 (K Units)
Figure 89. South Africa Favipiravir Value Growth 2015-2020 ($ Millions)
Figure 90. Israel Favipiravir Consumption Growth 2015-2020 (K Units)
Figure 91. Israel Favipiravir Value Growth 2015-2020 ($ Millions)
Figure 92. Turkey Favipiravir Consumption Growth 2015-2020 (K Units)
Figure 93. Turkey Favipiravir Value Growth 2015-2020 ($ Millions)
Figure 94. GCC Countries Favipiravir Consumption Growth 2015-2020 (K Units)
Figure 95. GCC Countries Favipiravir Value Growth 2015-2020 ($ Millions)
Figure 96. Global Favipiravir Consumption Growth Rate Forecast (2021-2025) (K Units)
Figure 97. Global Favipiravir Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 98. Americas Favipiravir Consumption 2021-2025 (K Units)
Figure 99. Americas Favipiravir Value 2021-2025 ($ Millions)
Figure 100. APAC Favipiravir Consumption 2021-2025 (K Units)
Figure 101. APAC Favipiravir Value 2021-2025 ($ Millions)
Figure 102. Europe Favipiravir Consumption 2021-2025 (K Units)
Figure 103. Europe Favipiravir Value 2021-2025 ($ Millions)
Figure 104. Middle East & Africa Favipiravir Consumption 2021-2025 (K Units)
Figure 105. Middle East & Africa Favipiravir Value 2021-2025 ($ Millions)
Figure 106. United States Favipiravir Consumption 2021-2025 (K Units)
Figure 107. United States Favipiravir Value 2021-2025 ($ Millions)
Figure 108. Canada Favipiravir Consumption 2021-2025 (K Units)
Figure 109. Canada Favipiravir Value 2021-2025 ($ Millions)
Figure 110. Mexico Favipiravir Consumption 2021-2025 (K Units)
Figure 111. Mexico Favipiravir Value 2021-2025 ($ Millions)
Figure 112. Brazil Favipiravir Consumption 2021-2025 (K Units)
Figure 113. Brazil Favipiravir Value 2021-2025 ($ Millions)
Figure 114. China Favipiravir Consumption 2021-2025 (K Units)
Figure 115. China Favipiravir Value 2021-2025 ($ Millions)
Figure 116. Japan Favipiravir Consumption 2021-2025 (K Units)
Figure 117. Japan Favipiravir Value 2021-2025 ($ Millions)
Figure 118. Korea Favipiravir Consumption 2021-2025 (K Units)
Figure 119. Korea Favipiravir Value 2021-2025 ($ Millions)
Figure 120. Southeast Asia Favipiravir Consumption 2021-2025 (K Units)
Figure 121. Southeast Asia Favipiravir Value 2021-2025 ($ Millions)
Figure 122. India Favipiravir Consumption 2021-2025 (K Units)
Figure 123. India Favipiravir Value 2021-2025 ($ Millions)
Figure 124. Australia Favipiravir Consumption 2021-2025 (K Units)
Figure 125. Australia Favipiravir Value 2021-2025 ($ Millions)
Figure 126. Germany Favipiravir Consumption 2021-2025 (K Units)
Figure 127. Germany Favipiravir Value 2021-2025 ($ Millions)
Figure 128. France Favipiravir Consumption 2021-2025 (K Units)
Figure 129. France Favipiravir Value 2021-2025 ($ Millions)
Figure 130. UK Favipiravir Consumption 2021-2025 (K Units)
Figure 131. UK Favipiravir Value 2021-2025 ($ Millions)
Figure 132. Italy Favipiravir Consumption 2021-2025 (K Units)
Figure 133. Italy Favipiravir Value 2021-2025 ($ Millions)
Figure 134. Russia Favipiravir Consumption 2021-2025 (K Units)
Figure 135. Russia Favipiravir Value 2021-2025 ($ Millions)
Figure 136. Spain Favipiravir Consumption 2021-2025 (K Units)
Figure 137. Spain Favipiravir Value 2021-2025 ($ Millions)
Figure 138. Egypt Favipiravir Consumption 2021-2025 (K Units)
Figure 139. Egypt Favipiravir Value 2021-2025 ($ Millions)
Figure 140. South Africa Favipiravir Consumption 2021-2025 (K Units)
Figure 141. South Africa Favipiravir Value 2021-2025 ($ Millions)
Figure 142. Israel Favipiravir Consumption 2021-2025 (K Units)
Figure 143. Israel Favipiravir Value 2021-2025 ($ Millions)
Figure 144. Turkey Favipiravir Consumption 2021-2025 (K Units)
Figure 145. Turkey Favipiravir Value 2021-2025 ($ Millions)
Figure 146. GCC Countries Favipiravir Consumption 2021-2025 (K Units)
Figure 147. GCC Countries Favipiravir Value 2021-2025 ($ Millions)
Figure 148. Fujifilm Toyama Chemical Favipiravir Market Share (2018-2020)
Figure 149. CSPC Pharmaceutical Group Favipiravir Market Share (2018-2020)
Figure 150. Sihuan Pharmaceutical Favipiravir Market Share (2018-2020)
Figure 151. Hisun Pharm Favipiravir Market Share (2018-2020)
Figure 152. Reyoung Pharmaceutical Favipiravir Market Share (2018-2020)
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets